The General Surgery and Thoracic Robotics Program
The Robotics program started at St. Luke’s – Roosevelt Hospital Center approximately 10 years ago. Surgeons at St. Luke’s – Roosevelt performed the first thymectomy for Myasthenia Gravis in the United States, the first robotic bi-ventricular lead placement for heart pacing in the world, and one of the first three-hole robotic esophagectomy for esophageal cancer in the United States.
Outcomes driven Innovation
A center of innovation, it is also one dedicated to successful outcomes. Dr. Belsley participates with Robotics Credentialing on the Credentialing committee of the St. Luke’s – Roosevelt Medical board. Dr. Bhora participates in the p4p database and Dr. Connery manages the Thoracic Cancer Registry as well as the Society of Thoracic Surgery outcomes database. We have made our best efforts to research effective therapies, innovate, and then apply our findings in a safe manner. We regularly publish our findings in peer-reviewed journals.
Scott J. Belsley, MD, FACS
Dr. Belsley has been working with the St. Luke's - Roosevelt Robotics Program in a variety of capacities since its inception 10 years ago. He typically reserves robotic surgery only for the procedures that show the greatest hypothetical benefit with the system. Most hernias and bariatric surgery procedures can be performed with standard laparoscopy.
Dr. Belsley is Director of Robotic Surgery at St. Luke's - Roosevelt Hospital Center. He assists in the credentialing, standardization and evaluation of robotic procedures in general and thoracic surgery. He has a special interest in robotic myotomy for achalasia and paraesophageal hernia repair and collaborates with Drs. Connery and Bhora with regards to robotic thoracic procedures.
Cliff P. Connery, MD, FACS
Dr. Connery is recognized for his skill in treating patients with lung and esophageal cancers as well as mediastinal tumors, thymomas and patients with myasthenia gravis. He is skilled in minimally invasive, video-assisted and robotic procedures as well as complex thoracic resections and reconstructions. He is an expert in the management of hyperhidrosis and the indications for sympathectomy.
Cliff P. Connery, M.D. FACS is Director of the Comprehensive Thoracic Oncology Program of Continuum Cancer Centers of New York an overall Chief of Thoracic Surgery for St Luke’s and Roosevelt Hospitals and Beth Israel Medical Center.
The Thoracic Oncology Program is a multi-disciplinary group that is able to offer the patient with thoracic malignancies state-of-the-art or even novel treatments in a coordinated, personalized, compassionate manner. Treatments are available for all stages of disease including prevention, screening and supportive care.
Under his guidance the Thoracic Surgery Divisions have been recognized internationally for the development of innovative treatments for patients with benign and malignant disorders of the chest. There is extensive capability in minimally invasive techniques with a particular interest in robotics.
Faiz Y. Bhora, MD,FACS
Dr. Bhora is also nationally known for his expertise in advanced bronchoscopic surgery involving the airway, including airway stenting for lung and thoracic cancer. He has developed one of the largest interventional airway programs in the region and frequently is able to offer treatment with excellent outcomes to even the most complex of patients.
Faiz Y. Bhora, MD, FACS, is the Director of Thoracic Surgical Oncology and Thoracic Surgery Research, Co-Director of the Airway Program, and the Associate Program Director of General Surgery at St. Luke’s and Roosevelt Hospitals and Continuum Cancer Centers of New York. He is also an Assistant Clinical Professor of Surgery at Columbia University College of Physicians and Surgeons and President of the New York General Thoracic Surgical Club, which includes all thoracic surgeons in the tri-state area.
Dr. Bhora's area of interest and specialty is Thoracic Oncology Surgery, involving complex lung resections and esophageal cancer. He specializes in minimally invasive approaches to thoracic disease and in the use of the Da Vinci surgical robot to perform minimally invasive lung resections, esophageal resections, thymectomy for myasthenia gravis and resection of other mediastinal masses.